These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment. Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599 [TBL] [Abstract][Full Text] [Related]
5. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports. Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272 [TBL] [Abstract][Full Text] [Related]
6. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation. Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675 [TBL] [Abstract][Full Text] [Related]
7. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
8. A novel approach to successful ABO-incompatible high-titer renal transplantation. Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol. Ando T; Tojimbara T; Sato S; Nakamura M; Kawase T; Kai K; Nakajima I; Fuchinoue S; Teraoka S Transplant Proc; 2004 Sep; 36(7):2182-3. PubMed ID: 15518793 [TBL] [Abstract][Full Text] [Related]
10. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409 [TBL] [Abstract][Full Text] [Related]
11. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results. Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971 [TBL] [Abstract][Full Text] [Related]
15. Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients. Ignjatović L; Kovacević Z; Jovanović D; Vavić N; Paunić Z; Radojević M; Rabrenović V; Obrencević K; Mijusković M; Draskovic-Pavlović B; Ostojić G; Balint B; Bokonjić D Vojnosanit Pregl; 2009 Feb; 66(2):117-22. PubMed ID: 19281122 [TBL] [Abstract][Full Text] [Related]
16. Effect of basiliximab on renal allograft rejection within 1 year after transplantation. Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988 [TBL] [Abstract][Full Text] [Related]
17. Experience with laparoscopic splenectomy for ABO-incompatible living renal transplantation without plasmapheresis. Hayashi T; Tahara H; Hara Y; Ishii T; Uemura H Transplant Proc; 2006 Sep; 38(7):1985-6. PubMed ID: 16979973 [TBL] [Abstract][Full Text] [Related]
18. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Kondo T; Shimmura H; Setoguchi K; Toma H Transplant Proc; 2004 Sep; 36(7):2175-7. PubMed ID: 15518791 [TBL] [Abstract][Full Text] [Related]
19. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408 [TBL] [Abstract][Full Text] [Related]
20. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans. Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]